Combination
GLOW Stack
Vendor nickname · no combination trial
GLOW is a catalog name, not an INN and not a trial arm. Most grey-market bottles that use the word are GHK-Cu-heavy three-peptide cakes. The math below is for a common advertised 70 mg 5:1:1 SKU. Your COA is the only ratio that matters.
Components
- GHK-Cu — Gly-His-Lys copper complex. Pickart dermal/matrikine literature and topical cosmetics are the honest file. “4000 genes / reverse biological age” is marketing. I…
- BPC-157 — A 15-amino-acid fragment studied mostly in animal models of tendon, ligament, gut, and vascular repair. Popular in recovery protocols; not approved for human us…
- TB-500 — Synthetic N-acetyl heptapeptide (Ac-LKKTETQ) matching thymosin β4 residues 17–23, the actin-binding loop. Research-chem SKU is this fragment (~889 Da), not the …
Evidence limits (from leaf)
- No published trial of GHK-Cu + BPC-157 + TB-500 together. Component papers are not stack papers.
- Do not treat full-length thymosin β4 papers as the 7-mer in the blend.
- Copper + multiple lyophilized peptides: confirm each mg on the COA. If the split is not 50/10/10, ignore the example tables.
Verdict
GLOW on vendor menus is usually GHK-Cu + BPC-157 + TB-500, not Argireline + Matrixyl. A 70 mg 5:1:1 label is a common advertised split, not a monograph. A mixed vial is not a synergy trial. Use the blend calculator.
Do the math
Confirm each milligram on the COA, then use the blend calculator. A mixed vial is not a synergy trial.
Blend / stack calculator